Hyaluronat sodium | ostenil syringe 20 mg / 2 ml, 1 pc.

Release form

Injection

Packaging

1 syringe.

Pharmacological action

OSTENIL contains a special fraction of high-purity sodium hyaluronate (hyaluronan - hyaluronic acid in the form of sodium salt) obtained by bacterial fermentation. The product does not contain animal proteins, which reduces the risk of an allergic reaction, and a narrow molecular weight range helps to ensure the absence of lungs that cause inflammation, fragments of hyaluronic acid. Sterilized by autoclaving. A standardized method of obtaining the active principle provides high efficiency and consistency of therapeutic qualities.

Indications

Intra-articular administration of ostenil is indicated for pain and limited mobility with degenerative-dystrophic and traumatic changes in the hip, knee and other synovial joints.

Contraindications

Ostenil should not be used by patients suffering from a pronounced sensitivity to one of the components.

Use during pregnancy and lactation

Not recommended for use in children, pregnant and lactating women.

Special instructions

The drug with signs of damage to the sterile packaging or syringe, as well as an expired Expiration (indicated on the box) is not to be used.

Composition

1 ml contains:

Active ingredient: 10.0 mg sodium hyaluronate

Excipients: sodium chloride, sodium monohydrogen phosphate, sodium dihydrogen phosphate, water for injection.

Dosage and administration of

Intra-articular. Allowed to be used exclusively by a doctor.

Ostenil® Plus is injected into the cavity of the affected joint once. According to indications, treatment can be supplemented with 1-2 injections with an interval of 14 days. At the same time, injections can be made into other joints.

If there is effusion in the joint, it must first be evacuated, the joint should be at rest, and cold therapy or intra-articular administration of a corticosteroid should be used. Treatment with a medical device Ostenil® Plus can begin 2–3 days after these procedures.

The contents and external surface of the filled syringe with the medical device Ostenil® Plus are sterile until the integrity of the packaging and the syringe closure of the syringe are compromised. The capping system consists of a protective cap, Luer tip and a cover to protect against unauthorized opening.

Before the injection is necessary: ​​Remove the filled syringe with the medical device Ostenil® Plus from the sterile packaging.

Fold over the cover to protect against unauthorized opening of the syringe on one side or the other so that its locking jumpers break.

Carefully lift off the cover with the protective cap.

Attach a sterile needle of the required size (18–25 G) and secure it by turning slightly.

Before injection, release air bubbles from the syringe if any.

Adverse effects

After the treatment, there is a pain, there is a pain, it can cause pain redness and swelling. The application of ice on the punctured joint for 5–10 min allows the relief of such phenomena.

Storage conditions

At 2–25 РC (do not freeze)

Term hodnosty

2 years

Deystvuyuschee substances

Hyaluronat sodium

Dosage form

injection solution

Hemedika, Germany